Lupin Ltd — Board/Management Information 2020

Nov 10, 2020

November 10, 2020

BSE Limited Department of Corporate Services, P. J. Towers, Dalal Street, MUMBAI - 400 001.

v National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051.

Dear Sir/Madam.

Sub: Disclosure pursuant to Regulation 30 (2) read with Schedule III Part A Para A(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').

We wish to inform you that the Board of Directors of the Company appointed Mr. Robert Funsten (DIN: 08950420) as an Independent Director of the Company, for a period of six months effective November 10, 2020. Pursuant to the provisions of Section 161 of the Companies Act, 2013 and Rules made thereunder, Mr. Funsten has been appointed as an Additional Director.

Mr. Robert Funsten is the Co-Chair of the Global Life Sciences Group of the law firm Brown Rudnick LLP in the USA and is Of Counsel to Brown Rudnick's Corporate practice. He has over twenty-five years of experience working with and advising life sciences companies in transactional, M&A and other matters.

This may kindly be considered as a disclosure pursuant to Regulation 30 of the Listing Regulations.

Thanking you,

Yours faithfully, FOR LUPIN LIMITED

R.V. SATAM COMPANY SECRETARY (ACS-11973)

LUPIN LIMITED

Registered Office: 3rd Floor, Kalpataru Inspire, Off W. E. Highway, Santacruz (East), Mumbai - 400 055 India. Tel : (91-22) 6640 2323. Corporate Identity Number: L24100MH1983PLC029442 www.lupin.com